Dry Herb Cannabis Vaporizers Market

Dry Herb Cannabis Vaporizers Market

The Global Dry Herb Cannabis Vaporizers Market reached USD 2.58 billion in 2023, with an anticipated CAGR of 14.6% from 2024 to 2032. Growth in this market is largely fueled by the rising endorsement of cannabis for both therapeutic and recreational purposes, which has expanded consumer access and acceptance worldwide.

A rise in chronic health conditions also contributes significantly to market demand as more individuals turn to cannabis for its potential therapeutic effects, especially in controlling chronic pain, inflammation, anxiety, and depression. Vaporizers provide a popular alternative to traditional smoking, offering a better consumption procedure by decreasing exposure to unsafe supplements.

The market is segmented by product type into tabletop and portable vaporizers, with portable options leading the industry in 2023 and generating USD 1.93 billion in revenue. Portable vaporizers are expected to grow at a CAGR of 14.8% during the forecast period. Their popularity stems from their convenience, compact size, and mobility, appealing to a broad consumer base. Advanced features such as Bluetooth connectivity, rapid heating, and USB charging enhance their appeal to tech-savvy users, while simple, user-friendly designs attract both beginners and experienced consumers.

Based on heating methods, the market is divided into conduction, convection, and induction. In 2023, conduction heating dominated, holding a 44% market share and is projected to grow at a CAGR of 13.9%. Conduction vaporizers deliver an efficient vaping experience, heating the herb directly through contact with a hot surface for rapid vapor production. This immediate heat-up feature meets the demands of users who prioritize convenience and fast results, and the straightforward design appeals particularly to beginners.

Europe leads the market, generating approximately USD 900 million in 2023, and projected to grow at a CAGR of 15.9%. This dominance is largely due to the legalization of cannabis for medical use across various European nations, driven by the rising prevalence of conditions like anxiety, depression, and inflammation. Cannabis’s therapeutic potential is increasingly recognized, yet recreational use remains strictly regulated in several areas. This evolving legal landscape has fostered a more accessible market, encouraging innovation and investment in vaporization products across the region.